Armistice Capital’s Azora Therapeutics AZR Stock Holding History
Bought
Maintained
Sold
Other funds holding AZR
Armistice Capital's AZR Position: Q1 2026 in Review
Armistice Capital sold out of Azora Therapeutics (AZR) in Q1 2026, closing a stake of 102,178 shares — an estimated $562K sold.
Armistice Capital first reported a position in AZR in Q1 2022 and held it in 3 quarters. The position peaked at $3.65M in Q1 2022. 15 funds tracked by Wall St. Rank hold AZR as of Q1 2026.
- Armistice Capital reported no remaining Azora Therapeutics position as of Q1 2026 after selling out during the quarter.
- Armistice Capital sold 102,178 Azora Therapeutics shares in Q1 2026, an estimated $562K.
- Armistice Capital first reported a position in Azora Therapeutics in Q1 2022 and held it in 3 quarters.
- Armistice Capital's Azora Therapeutics position peaked at $3.65M in Q1 2022.
- 15 funds tracked by Wall St. Rank held Azora Therapeutics as of Q1 2026.
Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.